Drugs / ADU-623
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01967758 | Jan 2014 → Jun 2018 | anaplastic astrocytoma, brain neoplasm, glioblastoma | Providence Health & Services | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ADU-623 | “The study will test a vaccine called ADU-623.” NCT01967758 ↗ |
| Modality | Vaccine | “The study will test a vaccine called ADU-623.” NCT01967758 ↗ |